MoonLake discloses mid-stage arthritis win Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

Mon T W Th F 23 February, 2026

Rethink what's possible for mature products — Download the playbook sponsored by Cencora

presented by Health Eco­nom­ic Out­comes of the On­co­type DX Breast Re­cur­rence Test at a Pop­u­la­tion Health Lev­el

news Updated: Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial Gilead to acquire cell therapy partner Arcellx for $7.8B MoonLake has 'a lot of confidence' ahead of FDA submission, discloses mid-stage arthritis win Vanda gets FDA approval for ‘franchise-extending’ antipsychotic

Client Engagement Mgr - Life Sciences Strategy & Intelligence Sedulo Group United States Vice President, Drug Metabolism & Pharmacokinetics (DMPK) C4 Therapeutics Watertown, MA, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

Innovation in biopharmaceuticals: A conversation with Fujifilm leaders sponsored by Fujifilm From structure to selectivity: Federated AI for collaborative binding affinity prediction sponsored by Rhino Federated Computing

After years of rough sledding, biotech investors are getting back to work. Join us for a data-driven look at the field’s top VCs and their strategies for 2026. Get your spot now.

in case you missed it 1. Supreme Court tariff ruling lets stand Trump’s authority to target pharma  2. Ionis scraps Alzheimer’s drug for people with Down syndrome 3. After rallying, Grail's cancer test faces new uncertainty due to UK study 4. Peer Review Sanofi appoints specialty care head; Biogen chair to retire in June 5. Daiichi taps John Tsai to lead R&D as Ken Takeshita departs 6. News Briefing Candel prices offering, signs royalty deal; Calquence label expands 7. Novartis to divest India unit to private equity-led consortium for $159M  8. More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds